202 related articles for article (PubMed ID: 28914259)
1. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
[No Abstract] [Full Text] [Related]
2. Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.
Mehrpouri M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M; Bashash D
Eur J Pharmacol; 2020 May; 875():173050. PubMed ID: 32142770
[TBL] [Abstract][Full Text] [Related]
3. The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.
Garrido Castro P; van Roon EHJ; Pinhanços SS; Trentin L; Schneider P; Kerstjens M; Te Kronnie G; Heidenreich O; Pieters R; Stam RW
Leukemia; 2018 Feb; 32(2):323-331. PubMed ID: 28690313
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.
Quagliano A; Gopalakrishnapillai A; Barwe SP
Leuk Res; 2017 May; 56():36-43. PubMed ID: 28171800
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL.
Cancer Discov; 2014 May; 4(5):OF11. PubMed ID: 24795015
[TBL] [Abstract][Full Text] [Related]
6. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Knoechel B; Roderick JE; Williamson KE; Zhu J; Lohr JG; Cotton MJ; Gillespie SM; Fernandez D; Ku M; Wang H; Piccioni F; Silver SJ; Jain M; Pearson D; Kluk MJ; Ott CJ; Shultz LD; Brehm MA; Greiner DL; Gutierrez A; Stegmaier K; Kung AL; Root DE; Bradner JE; Aster JC; Kelliher MA; Bernstein BE
Nat Genet; 2014 Apr; 46(4):364-70. PubMed ID: 24584072
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice.
Zhang H; Cheng H; Wang Y; Zheng Y; Liu Y; Liu K; Xu J; Hao S; Yuan W; Zhao T; Cheng T
Blood Cancer J; 2016 Jul; 6(7):e444. PubMed ID: 27391576
[No Abstract] [Full Text] [Related]
8. A Therapeutically Targetable NOTCH1-SIRT1-KAT7 Axis in T-cell Leukemia.
Lancho O; Singh A; da Silva-Diz V; Aleksandrova M; Khatun J; Tottone L; Nunes PR; Luo S; Zhao C; Zheng H; Chiles E; Zuo Z; Rocha PP; Su X; Khiabanian H; Herranz D
Blood Cancer Discov; 2023 Jan; 4(1):12-33. PubMed ID: 36322781
[TBL] [Abstract][Full Text] [Related]
9. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
10. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
11. NOTCH1 mutation can be an early, prenatal genetic event in T-ALL.
Eguchi-Ishimae M; Eguchi M; Kempski H; Greaves M
Blood; 2008 Jan; 111(1):376-8. PubMed ID: 17901244
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia.
Jiang C; Qian M; Gocho Y; Yang W; Du G; Shen S; Yang JJ; Zhang H
Blood Adv; 2022 Apr; 6(8):2496-2509. PubMed ID: 35192680
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia.
Mummery A; Narendran A; Lee KY
Curr Cancer Drug Targets; 2011 Sep; 11(7):882-93. PubMed ID: 21762078
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia.
Kobayashi M; Bai Y; Chen S; Gao R; Yao C; Cai W; Cardoso AA; Croop J; Zhang ZY; Liu Y
Leukemia; 2017 Mar; 31(3):751-754. PubMed ID: 27872499
[No Abstract] [Full Text] [Related]
15. T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF
Haematologica; 2019 May; 104(5):e204-e207. PubMed ID: 30514801
[No Abstract] [Full Text] [Related]
16. Developmental strategies for evasion of Arf tumor suppression.
Volanakis EJ; Sherr CJ
Cell Cycle; 2010 Jan; 9(1):14-5. PubMed ID: 20009580
[No Abstract] [Full Text] [Related]
17. Targeting NOTCH1 in T-ALL: Starving the dragon.
Herranz D; Ferrando AA
Cell Cycle; 2016; 15(4):483-4. PubMed ID: 26864725
[No Abstract] [Full Text] [Related]
18. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
Gianni F; Belver L; Ferrando A
Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
[TBL] [Abstract][Full Text] [Related]
19. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.
Gómez-del Arco P; Kashiwagi M; Jackson AF; Naito T; Zhang J; Liu F; Kee B; Vooijs M; Radtke F; Redondo JM; Georgopoulos K
Immunity; 2010 Nov; 33(5):685-98. PubMed ID: 21093322
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
